Latest Interviews - Finance News Network

06 Aug 2025 - We break down the difference between minted coins, rectangular coins, minted bars, cast bars and sovereigns.

06 Aug 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.

01 Aug 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.

01 Aug 2025 - AI platform revolutionising pharmaceutical quality control

29 July 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.

Why the metal deserves a long-term place in diversified portfolios

A look inside Australia's only government-owned precious metals business

18 July 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz emphasise staying rooted in fundamentals and deliberately avoiding media-driven noise and panic

16 July 2025 - Advances in GaN laser performance target quantum, biotech, and secure communications markets

14 July 2025 - Progress in cancer and autoimmune disease treatment

14 July 2025 - Gold and silver both shine as trusted stores of wealth, but choosing between them depends on a few factors. Here's 5 things to consider when buying gold or silver.

01 July 2025 - Opportunities Across Sectors: Cancer Treatment, Critical Minerals, Natural Gas, Materials - Live ASX Company Webinar

27 June 2025 - A look at The Perth Mint's services and investment offerings, from bullion to ASX-listed products.

23 June 2025 - Large-cap quality, downside protection and shareholder returns

17 June 2025 - How Bob Sahota turned a defensive credit philosophy into one of Australia's most respected private debt funds.

13 June 2025 - Opportunities Across Sectors: Cybersecurity, Copper, Life Sciences, and Platinum Group Metals

03 June 2025 - How Mirrabooka manages ris, navigates volatility and uncovers value.

02 June 2025 - Tariff shocks, central bank inertia, defensive positioning.

27 May 2025 - The structure and portfolio advantages of investing in LICs.

26 May 2025 - Strong results in soft tissue sarcoma have capped off a busy quarter of immunotherapy progress

20 May 2025 - Navigating market headwinds with defensive tilt in 2Q25

13 May 2025 - Mission-critical communications with global expansion potential.

13 May 2025 - Cameron Cormack, Senior Portfolio Manager at VanEck, on ETF strategy and market outlook

12 May 2025 - Phil Smith, a Director at AL Capital, discusses the company's strategy and focus on capital protection.

12 May 2025 - Chairman James Walker discusses funding, contracts, and commercial momentum for 2025.

23 Apr 2025 - The road to commercialisation: Overcoming funding and regulatory hurdles in battery storage

21 Apr 2025 - Navigating the FDA Process and Clinical Trial Hurdles

16 Apr 2025 - Managing Director Jarrad Haynes shares how the firm is navigating risk, scaling development, and positioning for long-term growth.

09 Apr 2025 - Martin Stein discusses the supply chain, environmental, and ethical challenges of lithium-ion batteries and the benefits of Altech's alternative

07 Apr 2025 - The Final Steps in Drug Development and Market Access

02 Apr 2025 - Mike Huang on Glow's vision for full-spectrum women's health—and what comes next

26 Mar 2025 - The pros and cons of lithium and CERENERGY grid storage batteries

19 Mar 2025 - Michael Fazzini, Sales and Distribution Executive at Capital Prudential, discusses the company's strategy.

17 Mar 2025 - LAG-3 and the Role of Immune Checkpoints in Cancer Treatment

12 Mar 2025 - The demand for grid storage batteries in Europe

12 Mar 2025 - The launch of Sofdra and what's next for Botanix

12 Mar 2025 - Sofdra's rollout and the path to $100m revenue

11 Mar 2025 - Delivering predictable income streams through disicplined development

10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments

10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth

07 Mar 2025 - Markets, valuations, and volatility: What investors need to know

04 Mar 2025 - Opportunities for fixed-rate bond investors

03 Mar 2025 - Addressing Unmet Needs in Cancer Care

24 Feb 2025 - Immuno-oncology's Expanding Role in Cancer Treatment

14 Feb 2025 - Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events.

07 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.

05 Feb 2025 - CEO Andrew Terry discusses long-range wi-fi, semiconductor challenges, and the future of IoT connectivity.

17 Jan 2025 - Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events.

16 Jan 2025 - Off the Chain Capital's CIO Brian Estes discusses Bitcoin's ethical implications, investment metrics, and future outlook.

13 Dec 2024 - Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.

11 Dec 2024 - INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.